Meta-analysis of gemcitabine in brief versus prolonged low-dose infusion for advanced non-small cell lung cancer

OBJECTIVE: To evaluate the efficacy and safety of gemcitabine (GEM) at 30 min standard-dose infusion (30 min-SDI) compared with prolonged low-dose infusion (P-LDI) in patients with advanced non-small-cell lung cancer (NSCLC). METHODS: Electronic databases including Pubmed, EMbase, Cochrane Library,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehua, Zhao, Mingming, Chu, Jisheng, Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862432/
https://www.ncbi.nlm.nih.gov/pubmed/29561887
http://dx.doi.org/10.1371/journal.pone.0193814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862432/
https://www.ncbi.nlm.nih.gov/pubmed/29561887
http://dx.doi.org/10.1371/journal.pone.0193814

Ejemplares similares